AAVantgarde presents positive clinical data from its AAVB-081 program for Usher 1B and preclinical data from its AAVB-039 program for Stargardt at the ARVO 2025 annual meeting
Notified -
Globe Newswire12-05-2025, 18:00
Equativ Unveils Maestro by Equativ: Its Most Advanced End-to-End Curation Platform for Enhanced Campaign Performance and Greater Control for Advertisers 22-01-2025, 20:09